603259 药明康德
已收盘 05-06 15:00:00
资讯
新帖
简况
药明康德(603259.SH)累计回购0.53%股份 耗资7.32亿元
智通财经 · 05-06 20:06
药明康德(603259.SH)累计回购0.53%股份 耗资7.32亿元
药明康德(02359)累计回购1566.53万股A股 耗资约7.32亿元
智通财经网 · 05-06 18:53
药明康德(02359)累计回购1566.53万股A股 耗资约7.32亿元
药明康德最新公告：4月累计以4亿元回购914万股公司股份
证券之星 · 05-06 18:41
药明康德最新公告：4月累计以4亿元回购914万股公司股份
药明康德(02359)5月6日耗资约2004.6万元回购约43.84万股A股
智通财经 · 05-06 18:16
药明康德(02359)5月6日耗资约2004.6万元回购约43.84万股A股
年报收官！医药行业“分红王”出炉 药明康德近50亿现金分红+回购回报股东
中金在线 · 05-06 16:48
年报收官！医药行业“分红王”出炉 药明康德近50亿现金分红+回购回报股东
小摩减持药明康德(02359)约64.02万股 每股作价约为34.98港元
智通财经 · 05-06 15:27
小摩减持药明康德(02359)约64.02万股 每股作价约为34.98港元
药明康德05月06日主力大幅流入3.28亿元 散户资金抛售
自选股智能写手 · 05-06 15:18
药明康德05月06日主力大幅流入3.28亿元 散户资金抛售
医疗，再度冲高！医疗ETF（512170）大涨超3%，强势站上60日均线！昭衍新药涨停，巨头药明康德劲涨超5%
新浪基金 · 05-06 10:19
医疗，再度冲高！医疗ETF（512170）大涨超3%，强势站上60日均线！昭衍新药涨停，巨头药明康德劲涨超5%
细胞免疫治疗概念盘中拉升，药明康德涨5.56%
自选股智能写手 · 05-06 10:10
细胞免疫治疗概念盘中拉升，药明康德涨5.56%
精准医疗概念盘中拉升，药明康德涨5.38%
自选股智能写手 · 05-06 10:06
精准医疗概念盘中拉升，药明康德涨5.38%
药明康德大幅上涨 近半年35家券商买入
智选洞察 · 05-06 10:04
药明康德大幅上涨 近半年35家券商买入
药明康德4月30日获融资净买入2917万元 环比增加1331.30%
自选股智能写手 · 05-06 10:00
药明康德4月30日获融资净买入2917万元 环比增加1331.30%
药明康德(02359)上涨5.19%，报38.5元/股
金融界 · 05-06 09:46
药明康德(02359)上涨5.19%，报38.5元/股
药明康德业绩承压首季营收净利双降 六大业务“五降一升”股价跌40%
市场资讯 · 05-06 07:19
药明康德业绩承压首季营收净利双降 六大业务“五降一升”股价跌40%
港股药明系普跌
第一财经 · 05-03
港股药明系普跌
药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有
新浪港股 · 05-03
药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有
【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳
金吾财讯 · 05-03
【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳
港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期
智通财经 · 05-03
港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期
【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股
金吾财讯 · 05-03
【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股
药明康德(02359)股价下跌5.045%，现价港币$36.7
阿斯达克财经 · 05-03
药明康德(02359)股价下跌5.045%，现价港币$36.7
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球生物医药行业提供一体化、端到端的新药研发和生产服务。公司主营业务可以分为化学业务、测试业务、生物学业务、细胞及基因疗法CTDMO业务、国内新药研发服务业务五大板块，服务范围覆盖从概念产生到商业化生产的整个流程，服务区域包括中国、美国、欧洲及其他区域。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":45.78,"timestamp":1714978800000,"preClose":43.67,"halted":0,"volume":126789066,"delay":0,"floatShares":2546000000,"shares":2933000000,"eps":3.1981,"marketStatus":"已收盘","marketStatusCode":5,"change":2.11,"latestTime":"05-06 15:00:00","open":44.44,"high":46.39,"low":44.34,"amount":5772000000,"amplitude":0.0469,"askPrice":45.79,"askSize":2194,"bidPrice":45.78,"bidSize":4433,"shortable":0,"etf":0,"ttmEps":3.1981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715045400000},"adr":0,"adjPreClose":43.67,"symbolType":"stock","openAndCloseTimeList":[[1714959000000,1714966200000],[1714971600000,1714978800000]],"highLimit":48.04,"lowLimit":39.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2933336997,"pbRate":2.41,"roa":"--","roe":"3.51%","epsLYR":3.27,"committee":-0.000069,"marketValue":134288000000,"floatMarketCap":116568000000,"peRate":14.314749,"changeRate":0.0483,"turnoverRate":0.0498,"status":0},"requestUrl":"/m/hq/s/603259/wiki","defaultTab":"wiki","newsList":[{"id":"2433225154","title":"药明康德(603259.SH)累计回购0.53%股份 耗资7.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433225154","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433225154?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:06","pubTimestamp":1714997184,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(603259.SH)发布公告，截至2024年4月30日，公司累计通过集中竞价交易方式回购A股股份1566.53万股，占公司公告日总股本的0.53%，回购最高价格人民币58.66元/股，回购最低价格人民币41.23元/股，使用资金总额人民币7.32亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117803.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433425611","title":"药明康德(02359)累计回购1566.53万股A股 耗资约7.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433425611","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2433425611?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:53","pubTimestamp":1714992798,"startTime":"0","endTime":"0","summary":"截至2024年4月30日，公司累计通过集中竞价交易方式回购A股股份1566.53万股，占公司本公告日总股本的0.53%，回购最高价格人民币58.66元/股，回购最低价格人民币41.23元/股，使用资金总额人民币约7.32亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117714.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433428047","title":"药明康德最新公告：4月累计以4亿元回购914万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433428047","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433428047?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:41","pubTimestamp":1714992084,"startTime":"0","endTime":"0","summary":"药明康德公告，2024年4月，公司回购A股股份914.6万股，占公司本公告日总股本的0.31%，使用资金总额4亿元(不含交易费用)。截至2024年4月30日，公司已累计回购股份1566.53万股，已支付的总金额约为7.32亿元（不含交易费用）。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600021270.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433644033","title":"药明康德(02359)5月6日耗资约2004.6万元回购约43.84万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433644033","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433644033?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:16","pubTimestamp":1714990618,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)公布，2024年5月6日耗资约2004.6万元回购约43.84万股A股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117665.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433445489","title":"年报收官！医药行业“分红王”出炉 药明康德近50亿现金分红+回购回报股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2433445489","media":"中金在线","top":-1,"share":"https://www.laohu8.com/m/news/2433445489?lang=zh_cn&edition=full","pubTime":"2024-05-06 16:48","pubTimestamp":1714985285,"startTime":"0","endTime":"0","summary":"在医药行业中，药明康德以其慷慨的股东回馈动作脱颖而出，成为业界的“分红”标杆。2023年，药明康德不仅业绩再创新高，现金分红总额更是达到了28.82亿元。综合来看，药明康德以总计48.82亿元的分红+回购总金额位居医药行业的首位。药明康德的分红举措是其长期坚持的企业文化的核心组成部分。药明康德通过持续的现金分红，确保股东能够直接受益于公司的盈利和成长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050616520187d7d4f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050616520187d7d4f4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433813417","title":"小摩减持药明康德(02359)约64.02万股 每股作价约为34.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433813417","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433813417?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:27","pubTimestamp":1714980461,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月26日，JPMorgan Chase & Co.减持药明康德(02359)64.024万股，平均每股作价34.9789港元，总金额约为2239.49万港元。减持后最新持股数目约为3427.80万股，持股比例为8.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117466.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433417645","title":"药明康德05月06日主力大幅流入3.28亿元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2433417645","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433417645?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:18","pubTimestamp":1714979929,"startTime":"0","endTime":"0","summary":"05月06日, 药明康德股价涨4.83%，报收45.78元，成交金额57.72亿元，换手率4.98%，振幅4.69%，量比1.39。药明康德今日主力资金净流入3.28亿元，上一交易日主力净流出3.49亿元。该股近5个交易日上涨9.10%，主力资金累计净流入2.93亿元；近20日主力资金累计净流出41.55亿元，其中净流出天数为14日。该行业中净流入前三个股分别为药明康德、爱尔眼科、通策医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061532248b78fb1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061532248b78fb1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433046795","title":"医疗，再度冲高！医疗ETF（512170）大涨超3%，强势站上60日均线！昭衍新药涨停，巨头药明康德劲涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433046795","media":"新浪基金","top":-1,"share":"https://www.laohu8.com/m/news/2433046795?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:19","pubTimestamp":1714961940,"startTime":"0","endTime":"0","summary":" 医疗，继续上攻！5月6日早盘，医疗板块再发力，场内热门医疗ETF跳空高开，截至发稿涨3.27%，强势站上60日均线！ 成份股方面，医疗服务、医疗器械携手上涨，昭衍新药涨停！通策医疗飙涨超8%，CXO巨头药明康德、医美龙头爱美客双双涨超5%！风险提示：医疗ETF及其联接基金被动跟踪中证医疗指数，该指数基日为2004.12.31，发布于2014.10.31，指数成份股构成根据该指数编制规则适时调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-05-06/doc-inaufyzf1688005.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-05-06/doc-inaufyzf1688005.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433046290","title":"细胞免疫治疗概念盘中拉升，药明康德涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433046290","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433046290?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:10","pubTimestamp":1714961437,"startTime":"0","endTime":"0","summary":"05月06日，细胞免疫治疗概念盘中拉升，截至10点10分，细胞免疫治疗概念整体指数上涨2.01%，报791.490点。从个股上来看，该概念的成分股中，药明康德涨5.56%，康泰生物涨幅超过5%。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为1.73亿，其中药明康德受到资金热捧，主力净流入3.56亿；拉长时间线来看，该板块近20日主力资金净流入-60.29亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506101037861eb0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506101037861eb0f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433464751","title":"精准医疗概念盘中拉升，药明康德涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433464751","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433464751?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:06","pubTimestamp":1714961213,"startTime":"0","endTime":"0","summary":"05月06日，精准医疗概念盘中拉升，截至10点06分，精准医疗概念整体指数上涨2.04%，报759.250点。从个股上来看，该概念的成分股中，药明康德涨5.38%，奕瑞科技、达安基因、贝达药业涨幅居前。从资金上来看，截止发稿，精准医疗概念主力净流入为2.01亿，其中药明康德受到资金热捧，主力净流入3.29亿；拉长时间线来看，该板块近20日主力资金净流入-57.00亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050610065387e85afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050610065387e85afc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433146720","title":"药明康德大幅上涨 近半年35家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2433146720","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2433146720?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:04","pubTimestamp":1714961065,"startTime":"0","endTime":"0","summary":"05月06日，药明康德股价大幅上涨，截至10点04分，药明康德上涨5.06%，报45.88元/股，成交25.37亿元，换手率2.21%。此外，数据统计显示，近半年内1家券商给予增持建议，35家券商给予买入建议。资金动向截止发稿，药明康德获得主力净流入2.68亿元，其中超大单流入2.92亿元，大单流出2400万元。北向资金方面，药明康德04月30日获得北向资金减持19.85万股，截至04月30日，北向资金当前共持有药明康德12554.53万股，市值57.60亿元，持股占流通股比为4.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061031497a582655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061031497a582655&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433647594","title":"药明康德4月30日获融资净买入2917万元 环比增加1331.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433647594","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433647594?lang=zh_cn&edition=full","pubTime":"2024-05-06 10:00","pubTimestamp":1714960807,"startTime":"0","endTime":"0","summary":"4月30日，药明康德获融资净买入2917万元，环比上一交易日增加1331.30%。其中，融资买入5.32亿元，融资偿还5.03亿元。融券方面，融券卖出4.61万股，当前融券余量为95.19万股。A股市场共有2042股获融资净买入，药明康德净买入额排名第31。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050610002387d65b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050610002387d65b2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433708461","title":"药明康德(02359)上涨5.19%，报38.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433708461","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433708461?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:46","pubTimestamp":1714959962,"startTime":"0","endTime":"0","summary":"5月6日，药明康德盘中上涨5.19%，截至09:46，报38.5元/股，成交1.63亿元。无锡药明康德新药开发股份有限公司是一家全球领先的一体化新药研发和生产服务提供商，主要通过其“CRDMO”和“CTDMO”业务模式，为全球生物医药行业提供包括化学药研发和生产、生物学研究、临床前测试和临床试验研究、细胞及基因疗法研发、测试和生产等在内的全方位服务。截至2024年一季报，药明康德营业总收入79.82亿元、净利润19.42亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/06094640522835.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433465780","title":"药明康德业绩承压首季营收净利双降 六大业务“五降一升”股价跌40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433465780","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2433465780?lang=zh_cn&edition=full","pubTime":"2024-05-06 07:19","pubTimestamp":1714951140,"startTime":"0","endTime":"0","summary":" 日前，药明康德披露2024年一季度报告，当期营收79.82亿元，同比下降10.95%；归母净利润19.42亿元，同比下降10.42%。此外，药明康德六大业务“五降一升”，仅测试业务实现微增2.6%，其余业务均录得不同程度下滑。 据了解，自今年1月底卷入美国生物安全法案风波后，药明康德的股价进入下降通道，1月25日收盘，公司股价收报73.29元/股，截至五一前收市，公司股价为43.67元/股，3个多月跌幅达40.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-05-06/doc-inaufuti1761390.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-05-06/doc-inaufuti1761390.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432944949","title":"港股药明系普跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2432944949","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2432944949?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:50","pubTimestamp":1714722603,"startTime":"0","endTime":"0","summary":"药明合联跌近11%，药明康德跌超5%，药明生物跌超4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031550037925bd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031550037925bd46&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432941019","title":"药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有","url":"https://stock-news.laohu8.com/highlight/detail?id=2432941019","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2432941019?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:48","pubTimestamp":1714722480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 5月3日，药明康德股票在香港一度下跌7.4%，创下4月5日以来最大盘中跌幅。截至发稿，跌幅收窄至5.6%。消息面上，招商证券此前将该股评级从买进下调为持有。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：常福强","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/jhzx/2024-05-03/doc-inatxumz6379630.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/jhzx/2024-05-03/doc-inatxumz6379630.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432551948","title":"【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2432551948","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2432551948?lang=zh_cn&edition=full","pubTime":"2024-05-03 14:17","pubTimestamp":1714717068,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际发研报指，药明康德 1Q业绩在艰难环境下表现平稳。收入同比下降11.0%至79.8亿元，剔除新冠商业化项目后收入同比下降1.8%，经调整non-IFRS净利润同比下降18.3%至19.1亿元。管理层维持2024年业绩指引，预计收入达到383至405亿元，剔除新冠商业化项目后将增长2.7至8.6%，同时预计non-IFRS净利率将保持与2023年相当的水平。该行维持药明康德买入评级，A股目标价由67.3元人民币下调至53.23元人民币。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200915/MGYzMDMzNGFiY2IxZDI0MzU2YTQ4NTEzZTUyODAwMDc0ODA2MTY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MGYzMDMzNGFiY2IxZDI0MzU2YTQ4NTEzZTUyODAwMDc0ODA2MTY2.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936241","is_publish_highlight":false,"gpt_icon":0},{"id":"2432181529","title":"港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432181529","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432181529?lang=zh_cn&edition=full","pubTime":"2024-05-03 11:26","pubTimestamp":1714706785,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股全线回落，截至发稿，药明康德跌6.47%，报36.15元；凯莱英跌5.33%，报63.05元；康龙化成跌4.96%，报9.96港元；泰格医药跌3.23%，报34.5港元。消息面上，药明康德2024年一季度实现营业收入79.82亿元，同比减少10.95%；归母净利润19.42亿元，同比减少10.42%。浦银国际指出，药明康德1Q24经调整Non-IFRS归母净利润低于预期。公司早期业务受行业融资疲软影响，考虑到降息预期已进一步推迟至2024年底，该行对早期业务收入增速持较为保守态度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117040.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432166994","title":"【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432166994","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2432166994?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:31","pubTimestamp":1714703485,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德(02359)股价表现疲软，截至发稿，报36.95港元，跌4.4%，成交额8131.2万港元。消息面上，根据香港联交所5月2日披露的文件，摩根大通(JPMorgan Chase & Co.)于4月26日以场内每股均价34.9789港元，场外每股均价34.9502港元合计售出药明康德64.02万股H股股份，价值约2,239.49万港元。售出后，摩根大通最新持股数目为3,427.8万股股份，好仓比例由9.02%降至8.85%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936217","is_publish_highlight":false,"gpt_icon":0},{"id":"2432786994","title":"药明康德(02359)股价下跌5.045%，现价港币$36.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2432786994","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432786994?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:25","pubTimestamp":1714703100,"startTime":"0","endTime":"0","summary":"[下跌股]药明康德(02359) 股价在上午10:25比前收市价下跌5.045%，现股价为港币$36.7。至目前为止，今日最高价为$39.1，而最低价为$36.7。总成交量为208.956万股，总成交金额为港币$7.918千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240503989/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","stockEarnings":[{"period":"1week","weight":0.0244},{"period":"1month","weight":-0.0544},{"period":"3month","weight":-0.1943},{"period":"6month","weight":-0.4885},{"period":"1year","weight":-0.3449},{"period":"ytd","weight":-0.3998}],"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"293334万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球生物医药行业提供一体化、端到端的新药研发和生产服务。公司主营业务可以分为化学业务、测试业务、生物学业务、细胞及基因疗法CTDMO业务、国内新药研发服务业务五大板块，服务范围覆盖从概念产生到商业化生产的整个流程，服务区域包括中国、美国、欧洲及其他区域。","serverTime":1715011856544,"listedPrice":21.6,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}